Atlas of Diffuse Lung Diseases A Multidisciplinary Approach 1st Edition by Giorgia Dalpiaz 3319427522 9783319427522

Atlas of Diffuse Lung Diseases A Multidisciplinary Approach 1st Edition by Giorgia Dalpiaz – Ebook PDF Instant Download/DeliveryISBN:  3319427522, 9783319427522 

Full download Atlas of Diffuse Lung Diseases A Multidisciplinary Approach 1st Edition after payment.

Product details:

ISBN-10 :  3319427522 

ISBN-13 : 9783319427522

Author: Giorgia Dalpiaz 

This atlas is designed as an easy-to-use reference guide that identifies and illustrates the key patterns of diffuse lung diseases observed on high-resolution computed tomography (HRCT) and then documents in more detail the characteristics and appearances of the individual diseases, grouped on the basis of their prevalent pattern. A further feature of the book is its interdisciplinary nature: contributions from experts in various specialties are tightly interwoven throughout and many pathologic correlations are included. Less experienced readers will find that this atlas, with its wealth of figures and helpful color coding, steers them towards correct interpretation when confronted by the multiplicity and complexity of these diseases; those who are already experts, on the other hand, will benefit from the detailed coverage of individual diseases, which will deepen their understanding. At the end of the book, a graphically appealing and practice-oriented illustrated glossary with tips and tricks offers a further highly effective educational tool. Given the clinical spectrum of diseases covered, this atlas will prove invaluable for a wide range of healthcare workers, especially radiologists, pulmonologists, and pathologists.

Atlas of Diffuse Lung Diseases A Multidisciplinary Approach 1st Table of contents:

1. The BEST Points of the Atlas
2. Contents
3. Clinical Approach to Diffuse Lung Diseases
4. Classification of DLDs
5. DLDs Associated to Known Causes
6. Idiopathic DLDs
7. Idiopathic DLDs
8. IPAF
9. Epidemiology and Prognosis
10. Clinical Evaluation
11. Acute Diseases
12. Subacute Diseases
13. Chronic Diseases
14. History
15. Key Pulmonary Symptoms and Signs
16. Dyspnea
17. Dry Cough
18. Chest Pain
19. Hemoptysis
20. Wheezing
21. Key Extrapulmonary Symptoms and Signs
22. Functional Testing
23. Spirometry
24. DLCO
25. Autoimmunity
26. Laboratory Findings
27. Systemic Symptoms and Signs
28. DLD in Sjögren’s Syndrome and in RA
29. The Most Frequent Clinical Settings
30. IPF
31. NSIP
32. COP
33. Sarcoidosis
34. Bronchoalveolar Lavage (BAL)
35. Bronchoalveolar Lavage (BAL)
36. Procedure
37. Normal Values
38. Diagnostic Role
39. BAL in Adenocarcinoma
40. BAL in CEP
41. BAL in DAD
42. BAL in DAH
43. BAL in Infection (e.g. Aspergillus, PJP)
44. BAL in LCH
45. BAL in Lipoid Pneumonia
46. BAL in IPF
47. BAL in Sarcoidosis
48. TBNA, EBUS-TBNA, EUS-FNA and EUS-B-FNA
49. TBNA, EBUS-TBNA, EUS-FNA and EUS-B-FNA
50. Procedures
51. Diagnostic Role
52. Transbronchial Biopsy (TBB)
53. Transbronchial Biopsy (TBB)
54. Procedure
55. Diagnostic Role
56. Complication Rate
57. Transbronchial Cryobiopsy
58. Transbronchial Cryobiopsy
59. Procedure
60. Diagnostic Role
61. Surgical Lung Biopsy in VATS
62. Surgical Lung Biopsy in VATS
63. Procedure
64. Diagnostic Role
65. The Multidisciplinary Approach (MDA)
66. The Multidisciplinary Approach (MDA)
67. The Role of MDA
68. Thinking Through Pathology
69. Introduction and Anatomy
70. Secondary Lobule
71. Main Components of Secondary Lobule
72. Intralobular Interstitium/Septa
73. HRCT
74. Elementary Lesions
75. Defining Lesions: Neoplasm
76. Multiple Neoplastic Nodules
77. Interstitial Neoplastic Thickening
78. Lepidic Growth
79. Partial or Complete Neoplastic Alveolar Filling
80. Peribronchial and Peribronchiolar Neoplastic Growth
81. Defining Lesions: Mixture
82. Hyaline Membranes
83. Pulmonary Alveolar Proteinosis (PAP)
84. Diffuse Alveolar Hemorrhage (DAH)
85. Amyloid
86. Microlitiasis
87. LAM
88. Necrosis
89. Non-defining Lesions: Inflammation
90. Diffuse Uniform Inflammation
91. Centrilobular Peribronchial Inflammation
92. Granulomas
93. Eosinophils
94. Non-defining Lesions: Fibrosis
95. “Young” Fibrosis
96. “Old” Fibrosis
97. Diffuse Fibrosis of Patchy Type
98. Diffuse Fibrosis of Uniform Type
99. Centrilobular Fibrosis
100. Peripheral Fibrosis
101. Lymphatic Distribution
102. How to Approach the Diseases
103. Anatomic Distribution
104. Bronchiolocentric
105. Angiocentric
106. Lymphatic
107. Septal
108. Peripheral
109. Pleural/Subpleural
110. Random
111. Interstitial
112. Intra-alveolar
113. Patterns
114. Acute Lung Injury (ALI)
115. Fibrosis
116. Cellular Infiltrate
117. Alveolar Filling
118. Nodules
119. Minimal Changes
120. Ancillary Histologic Findings
121. Septal Pattern
122. Septal Pattern
123. Septal Pattern
124. Definition
125. Septal Signs
126. Septal Signs
127. Septal Thickening
128. Subpleural Interstitial Thickening
129. Peribroncho-vascular Thickening
130. Subset Smooth
131. Subset Smooth
132. Subset Nodular
133. Subset Nodular
134. Septal Diseases
135. Amyloidosis, Interstitial
136. High-Resolution CT: HRCT
137. Definition
138. Key Signs
139. Distribution
140. Ancillary Signs
141. Non- parenchymal Signs
142. Course and Complications
143. Erdheim-Chester Disease (ECD)
144. High-Resolution CT: HRCT
145. Definition
146. Key Signs
147. Distribution
148. Ancillary Signs
149. Non- parenchymal Signs
150. Course and Complications
151. Lymphangitis Carcinomatosis (LC)
152. High-Resolution CT: HRCT
153. Definition
154. Key Signs
155. Distribution
156. Ancillary Signs
157. Non- parenchymal Signs
158. Course and Complications
159. Pulmonary Edema (PE), Interstitial
160. High-Resolution CT: HRCT
161. Definition
162. Key Signs
163. Distribution
164. Ancillary Signs
165. Non- parenchymal Signs
166. Course and Complications
167. Veno-occlusive Disease (VOD)
168. High-Resolution CT: HRCT
169. Definition
170. Key Signs
171. Distribution
172. Ancillary Signs
173. Non- parenchymal Signs
174. Course and Complications
175. Fibrosing Pattern
176. Fibrosing Pattern
177. Fibrosing Pattern
178. Definition
179. Fibrosing Key Signs
180. Fibrosing Key Signs
181. Honeycombing
182. Fibrosing Reticulation and Interface Sign
183. Traction Bronchiectasis and Bronchiolectasis
184. Volume Loss
185. Ancillary Signs
186. Ancillary Signs
187. Ground-�Glass Opacity
188. Lobular Air Trapping
189. Disseminated Pulmonary Ossification
190. Fibrosing Diseases
191. Asbestosis
192. High-Resolution CT: HRCT
193. Definition
194. Key Signs
195. Distribution
196. Ancillary Signs
197. Non- parenchymal Signs
198. Course and Complications
199. Collagen Vascular Disease (CVD): Scleroderma
200. High-Resolution CT: HRCT
201. Definition
202. Key Signs
203. Distribution
204. Ancillary Signs
205. Non- parenchymal Signs
206. Course and Complications
207. Drug Toxicity, Chronic: Methotrexate
208. High-Resolution CT: HRCT
209. Definition
210. Key Signs
211. Distribution
212. Ancillary Signs
213. Non- parenchymal Signs
214. Course and Complications
215. Hypersensitivity Pneumonitis (HP), Chronic
216. High-Resolution CT: HRCT
217. Definition
218. Key Signs
219. Distribution
220. Ancillary Signs
221. Non- parenchymal Signs
222. Course and Complications
223. Idiopathic Pulmonary Fibrosis (IPF)
224. High-Resolution CT: HRCT
225. Definition
226. Key Signs
227. Distribution
228. Ancillary Signs
229. Non- parenchymal Signs
230. Course and Complications
231. Nonspecific Interstitial Pneumonia (NSIP)
232. High-Resolution CT: HRCT
233. Definition
234. Key Signs
235. Distribution
236. Ancillary Signs
237. Non- parenchymal Signs
238. Course and Complications
239. Pleuroparenchymal Fibroelastosis (PPFE)
240. High-Resolution CT: HRCT
241. Definition
242. Key Signs
243. Distribution
244. Ancillary Signs
245. Non- parenchymal Signs
246. Course and Complications
247. Sarcoidosis, Chronic
248. High-Resolution CT: HRCT
249. Definition
250. Key Signs
251. Distribution
252. Ancillary Signs
253. Non- parenchymal Signs
254. Course and Complications
255. Nodular Pattern
256. Nodular Pattern
257. Definition
258. Nodular Signs
259. Low-density (subsolid) nodules
260. High Density (solid) Nodules
261. Cavitated Nodules
262. Calcified Nodules
263. Nodules with Halo Sign
264. Subset Lymphatic
265. Subset Random
266. Subset Centrilobular
267. Unusual Distribution of Small Nodules
268. Galaxy Sign
269. Nodular Cluster Sign
270. Nodular Reversed Halo Sign
271. Pseudoplaques
272. Nodular Diseases
273. Epithelioid Hemangioendothelioma (EHE)
274. High-Resolution CT: HRCT
275. Definition
276. Key Signs
277. Distribution
278. Ancillary Signs
279. Non- parenchymal Signs
280. Course and Complications
281. Follicular Bronchiolitis (FB)
282. High-Resolution CT: HRCT
283. Definition
284. Key Signs
285. Distribution
286. Ancillary Signs
287. Non- parenchymal Signs
288. Course and Complications
289. Hemorrhage in Endometriosis
290. High-Resolution CT: HRCT
291. Definition
292. Key Signs
293. Distribution
294. Ancillary Signs
295. Non- parenchymal Signs
296. Course and Complications
297. Hypersensitivity Pneumonitis (HP), Subacute
298. High-Resolution CT: HRCT
299. Definition
300. Key Signs
301. Distribution
302. Ancillary Signs
303. Non- parenchymal Signs
304. Course and Complications
305. Hot Tub Lung (HTL)
306. High-Resolution CT: HRCT
307. Definition
308. Key Signs
309. Distribution
310. Ancillary Signs
311. Non- parenchymal Signs
312. Course and Complications
313. Infection, Miliary Tuberculosis (TB)
314. High-Resolution CT: HRCT
315. Definition
316. Definition
317. Key Signs
318. Distribution
319. Ancillary Signs
320. Non- parenchymal Signs
321. Course and Complications
322. Langerhans Cell Histiocytosis (LCH), Early
323. High-Resolution CT: HRCT
324. Definition
325. Key Signs
326. Distribution
327. Ancillary Signs
328. Non- parenchymal Signs
329. Course and Complications
330. Lymphocytic Interstitial Pneumonia (LIP)
331. High-Resolution CT: HRCT
332. Definition
333. Key Signs
334. Distribution
335. Ancillary Signs
336. Non- parenchymal Signs
337. Course and Complications
338. Metastases, Hematogenous
339. High-Resolution CT: HRCT
340. Definition
341. Key Signs
342. Distribution
343. Ancillary Signs
344. Non- parenchymal Signs
345. Course and Complications
346. “Metastatic” Pulmonary Calcification (MPC)
347. High-Resolution CT: HRCT
348. Definition
349. Key Signs
350. Distribution
351. Ancillary Signs
352. Non- parenchymal Signs
353. Course and Complications
354. Pulmonary Capillary Hemangiomatosis (PCH)
355. High-Resolution CT: HRCT
356. Definition
357. Key Signs
358. Distribution
359. Ancillary Signs
360. Non- parenchymal Signs
361. Course and Complications
362. Respiratory Bronchiolitis Interstitial Lung Disease: RB-ILD
363. High-Resolution CT: HRCT
364. Definition
365. Key Signs
366. Distribution
367. Ancillary Signs
368. Non- parenchymal Signs
369. Course and Complications
370. Sarcoidosis
371. High-Resolution CT: HRCT
372. Definition
373. Key Signs
374. Distribution
375. Ancillary Signs
376. Non- parenchymal Signs
377. Course and Complications
378. Silicosis
379. High-Resolution CT: HRCT
380. Definition
381. Key Signs
382. Distribution
383. Ancillary Signs
384. Non- parenchymal Signs
385. Course and Complications
386. Alveolar Pattern
387. Alveolar Pattern
388. Definition
389. Alveolar Key Signs
390. Ground-Glass Opacity (GGO)
391. Consolidation
392. Ancillary Signs
393. Hypodense Consolidation
394. Hyperdense Consolidation
395. Cystic Consolidation
396. Crazy Paving
397. Head-Cheese Sign
398. Reversed Halo Sign
399. Perilobular Opacities
400. Lobular/Sublobular Opacities
401. Tree-in-Bud Sign, Bronchiolar
402. Subset Acute
403. Subset Chronic
404. Alveolar Diseases
405. Adenocarcinoma
406. High-Resolution CT: HRCT
407. Definition
408. Key Signs
409. Distribution
410. Ancillary Signs
411. Non-parenchymal Signs
412. Course
413. Acute Exacerbation of IPF (AE-IPF)
414. High-Resolution CT: HRCT
415. Definition
416. Key Signs
417. Distribution
418. Ancillary Signs
419. Non-parenchymal Signs
420. Course
421. Acute Eosinophilic Pneumonia (AEP)
422. High-Resolution CT: HRCT
423. Definition
424. Key Signs
425. Distribution
426. Ancillary Signs
427. Non-parenchymal Signs
428. Course
429. Acute Interstitial Pneumonia (AIP)
430. High-Resolution CT: HRCT
431. Definition
432. Key Signs
433. Distribution
434. Ancillary Signs
435. Non-parenchymal Signs
436. Course
437. Acute Respiratory Distress Syndrome (ARDS)
438. High-Resolution CT: HRCT
439. Definition
440. Key Signs
441. Distribution
442. Ancillary Signs
443. Non- parenchymal Signs
444. Course
445. Chronic Eosinophilic Pneumonia (CEP)
446. High-Resolution CT: HRCT
447. Definition
448. Key Signs
449. Distribution
450. Ancillary Signs
451. Non- parenchymal Signs
452. Course
453. Cryptogenic Organizing Pneumonia (COP)
454. Hi gh-Resolution CT: HRCT
455. Definition
456. Key Signs
457. Distribution
458. Ancillary Signs
459. Non- parenchymal Signs
460. Course
461. Diffuse Alveolar Hemorrhage (DAH) in Granulomatosis with Polyangiitis (GPA)
462. High-Resolution CT: HRCT
463. Definition
464. Key Signs
465. Distribution
466. Ancillary Signs
467. Non- parenchymal Signs
468. Course
469. Desquamative Interstitial Pneumonia (DIP)
470. High-Resolution CT: HRCT
471. Definition
472. Key Signs
473. Distribution
474. Ancillary Signs
475. Non- parenchymal Signs
476. Course
477. Drug Toxicity (Amiodarone)
478. High-Resolution CT: HRCT
479. Definition
480. Key Signs
481. Distribution
482. Ancillary Signs
483. Non- parenchymal Signs
484. Course
485. Fat Embolism Syndrome (FES)
486. High-Resolution CT: HRCT
487. Definition
488. Key Signs
489. Distribution
490. Ancillary Signs
491. Non- parenchymal Signs
492. Course and  Complications
493. Infection, Acute (PJP)
494. High-Resolution CT: HRCT
495. Definition
496. Key Signs
497. Distribution
498. Ancillary Signs
499. Non- parenchymal Signs
500. Course
501. Infection, Chronic: Tuberculosis (TB)
502. High-Resolution CT: HRCT
503. Definition
504. Key Signs
505. Distribution
506. Ancillary Signs
507. Non- parenchymal Signs
508. Course
509. Lipoid Pneumonia (LP)
510. High-Resolution CT: HRCT
511. Definition
512. Key Signs
513. Distribution
514. Ancillary Signs
515. Non- parenchymal Signs
516. Course
517. Mucosa-Associated Lymphatic Tissue Lymphoma (MALToma)
518. High-Resolution CT: HRCT
519. Definition
520. Key Signs
521. Distribution
522. Ancillary Signs
523. Non- parenchymal Signs
524. Course
525. Metastases, Aerogenous
526. High-Resolution CT: HRCT
527. Definition
528. Key Signs
529. Distribution
530. Ancillary Signs
531. Non- parenchymal Signs
532. Course
533. Pulmonary Alveolar Proteinosis (PAP)
534. High-Resolution CT: HRCT
535. Definition
536. Key Signs
537. Distribution
538. Ancillary Signs
539. Non- parenchymal Signs
540. Course
541. Pulmonary Edema (PE), Alveolar
542. High-Resolution CT: HRCT
543. Definition
544. Key Signs
545. Distribution
546. Ancillary Signs
547. Non- parenchymal Signs
548. Course
549. Cystic Pattern
550. Cystic Pattern
551. Cystic Pattern
552. Definition
553. Cystic Signs
554. Cystic Signs
555. Thin-Walled Cysts or Not-�Walled Cysts
556. Thick-Walled Cysts
557. Cysts with Irregular Shape
558. Cysts with Regular Shape
559. Bunch of Grapes Sign
560. Table of diseases
561. Incidental LungCysts
562. Cystic Diseases
563. Birt–Hogg–Dubè (BHD)
564. High-Resolution CT: HRCT
565. Definition
566. Key Signs
567. Distribution
568. Ancillary Signs
569. Non-parenchymal Signs
570. Course and Complications
571. Bronchiectasis, Cystic
572. High-Resolution CT: HRCT
573. Definition
574. Key Signs
575. Distribution
576. Ancillary Signs
577. Non-parenchymal Signs
578. Course and Complications
579. Cystic Fibrosis (CF)
580. High-Resolution CT: HRCT
581. Definition
582. Key Signs
583. Distribution
584. Ancillary Signs
585. Non-parenchymal Signs
586. Course and Complications
587. Combined Pulmonary Fibrosis and Emphysema (CPFE)
588. High-Resolution CT: HRCT
589. Definition
590. Key Signs
591. Distribution
592. Ancillary Signs
593. Non-parenchymal Signs
594. Course and Complications
595. Emphysema, Centrilobular, and Paraseptal
596. High-Resolution CT: HRCT
597. Definition
598. Key Signs
599. Distribution

People also search for Atlas of Diffuse Lung Diseases A Multidisciplinary Approach 1st:

    
what is a network assessment
    
what is network security with example
    
network security assessments
    
network security assessment checklist
    
network security assessment tool

Tags: Atlas, Diffuse, Lung Diseases, Multidisciplinary Approach, Giorgia Dalpiaz